Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver

Alice Bertocchi, Sara Carloni, Paola Simona Ravenda, +29

Cancer Cell

DysbiosisHepatologyBacteria DisseminationGut MicrobiologyGastroenterology +8

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer

Mariangela Russo, Giulia Siravegna, Lawrence S. Blaszkowsky, +20

Cancer Discovery

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

Filippo Pietrantonio, Federica Di Nicolantonio, Alexa B. Schrock, +29

JNCI Journal of the National Cancer Institute

Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer

Mariangela Russo, Sandra Misale, Wei Ge, +18

Cancer Discovery

Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer

Sandra Misale, Sabrina Arena, Simona Lamba, +14

Science Translational Medicine

Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer

Sabrina Arena, Beatríz Bellosillo, Giulia Siravegna, +22

Clinical Cancer Research

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

Beth O. Van Emburgh, Sabrina Arena, Giulia Siravegna, +19

Nature Communications

Crc SamplesColorectal CancersMedicineImmunologyCrc Patients +10

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer

Giulia Siravegna, Luca Lazzari, Giovanni Crisafulli, +34

Cancer Cell

MedicineHer2 BlockadeColorectal CancerPathologyIndividual Metastases +4

Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis

Alessandra Gentile, Luca Lazzari, Silvia Benvenuti, +2

Cancer Research

Tumor BiologyMet-driven TumorigenesisOncologyOncogenic AgentMedicine +12

RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells

Simona Lamba, Mariangela Russo, Chong Sun, +7

Cell Reports